{Reference Type}: Review
{Title}: Applications of mesenchymal stem cells in ocular surface diseases: sources and routes of delivery.
{Author}: Soleimani M;Masoumi A;Momenaei B;Cheraqpour K;Koganti R;Chang AY;Ghassemi M;Djalilian AR;
{Journal}: Expert Opin Biol Ther
{Volume}: 23
{Issue}: 6
{Year}: Jan-Jun 2023 31
{Factor}: 5.589
{DOI}: 10.1080/14712598.2023.2175605
{Abstract}: Mesenchymal stem cells (MSCs) are novel, promising agents for treating ocular surface disorders. MSCs can be isolated from several tissues and delivered by local or systemic routes. They produce several trophic factors and cytokines, which affect immunomodulatory, transdifferentiating, angiogenic, and pro-survival pathways in their local microenvironment via paracrine secretion. Moreover, they exert their therapeutic effect through a contact-dependent manner.<BR>In this review, we discuss the characteristics, sources, delivery methods, and applications of MSCs in ocular surface disorders. We also explore the potential application of MSCs to inhibit senescence at the ocular surface.<BR>Therapeutic application of MSCs in ocular surface disorders are currently under investigation. One major research area is corneal epitheliopathies, including chemical or thermal burns, limbal stem cell deficiency, neurotrophic keratopathy, and infectious keratitis. MSCs can promote corneal epithelial repair and prevent visually devastating sequelae of non-healing wounds. However, the optimal dosages and delivery routes have yet to be determined and further clinical trials are needed to address these fundamental questions.